Menu Search
Equities

Tenon Medical Inc

TNON:NAQ

Tenon Medical Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)5.47
  • Today's Change0.44 / 8.75%
  • Shares traded13.18m
  • 1 Year change-57.27%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Tenon Medical Inc grew revenues 323.73% from 691.00k to 2.93m while net income improved from a loss of 18.92m to a smaller loss of 15.58m.
Gross margin60.32%
Net profit margin-411.27%
Operating margin-412.13%
Return on assets-174.87%
Return on equity--
Return on investment-495.99%
More ▼

Cash flow in USDView more

In 2023, Tenon Medical Inc increased its cash reserves by 14.04%, or 299.00k. Cash Flow from Financing totalled 6.30m or 215.23% of revenues. In addition the company used 12.18m for operations while cash from investing totalled 6.14m.
Cash flow per share-37.96
Price/Cash flow per share--
Book value per share1.76
Tangible book value per share1.76
More ▼

Balance sheet in USDView more

Tenon Medical Inc uses little or no debt in its capital structure.
Current ratio1.20
Quick ratio1.02
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.